image credit- shutterstock
For people living with chronic kidney disease, dialysis is a long-term commitment that requires consistent access to specialised care. VitusCare, a dialysis care provider focused on expanding access to quality dialysis services across underserved markets, has secured $3 million in a Series B funding participated in by Singapore-based healthcare growth equity firm Liberty Ridge Capital, HDFC Bank, Equentis, NAFA Capital Advisors, existing investors 1Crowd and 3i Partners, and several angel investors.
The funding comes as VitusCare claims strong business growth. Since its previous funding round in late 2024, led by Tomorrow Capital, the company has nearly tripled its revenue. Its network has grown from 22 to over 60 dialysis centres across nine states and fifty-plus cities, with more than 35,000 patients treated and over 8 lakh dialysis sessions delivered.
The company has also grown its workforce from 110 to 300 employees. Faster breakeven at newly opened centres and same-centre growth exceeding 30% contributed to positive corporate EBITDA in FY26.
Gurugram-based VitusCare's expansion is built around a capital-light ‘shop-in-shop’ model that brings specialised dialysis services into existing hospitals. By partnering with hospitals rather than building standalone facilities, the company aims to extend its network while improving operational efficiency. It plans to expand to more than 100 centres by the end of FY27 and is exploring opportunities in select Asian markets.
The fresh capital will support the company's next phase of growth, including network expansion, technology development and workforce training. VitusCare is also investing heavily in various AI-native business modules to ensure the best possible health care delivery. It also plans to establish a Technician Academy to strengthen the pipeline of skilled dialysis professionals as it scales its operations.